The fourth national high-tech zone bio-pharmaceutical industrial cluster collaborative innovation meeting was held in Daxing district, Beijing, capital of Chinaon Sept. 27, 2018.
Totally 50 projects of high-grade, precision and advanced industries have signed a contract with Daxing Biological Pharmaceutical Industry Base, with a total investment of 10 billion yuan(1.45 billion U.S. dollars).
By 2025, Daxing will build a medicineand healthindustrial cluster of 100 billion yuan level.
The 50 projects are divided into five groups, namely, cooperation platform projects, international cooperation projects, medical apparatus and instruments projects,bio-pharmaceuticalprojects and industry funds projects,and each group consists of ten projects.
The 50 projects’ settlement in Daxing district will not only bring in world’s leading technologies and teams for the development of Daxing’s bio-pharmaceutical industry but also become a mainstay of the future medicine and health industrial cluster in Daxing, said Tian Dexiang, director of the administration committee of Daxing Biological Pharmaceutical Industry Base.
As Beijing’s special development space for bio-pharmaceutical industry, Daxing Biological Pharmaceutical Industry Base has become an important frontier of the capital to develop its high-end medicine & health manufacturing and sci-tech service industry.
So far, the base has formed a whole industry chain covering biological medicine, traditional Chinese medicine, innovation chemical medicine, medical apparatus and instruments and medicine&health.